Fibromyalgia pain responds to low-dose naltrexoneCustom compounded drug has ‘outstanding’ side-effect profile Rehab program tackles substance abuse, comorbid painMayo Clinic approach uses cognitive-behavioural therapy, exercise, other modalities Ontario College advice on managing switch from OxyContin Advisory follows fatality resulting from change in prescription from OxyContin to another opioid analgesic. Choosing the right topical pain reliever Natural alternatives for clients seeking pain relief. Tips for self-treating minor pain Pain management is enhanced when pharmacologic therapies are combined with physical and psychological approaches. Calculators for who should get low-dose ASA wildly divergent Various tools defined from 26% to 78% of same group as candidates for treatment Low-dose ASA over-prescribed Yet study shows it is hard to change FPs’ prescribing of low-dose ASA Chronic pain more common in kids than clinicians think: study Review says issue should be recognized as a major health concern in children and adolescents. OxyNEO soon to replace OxyContin Purdue Pharma will be discontinuing OxyContin at the end of this month. Clinical Notes: Buprenorphine/naloxone guidelines for opioid dependence CAMH releases new guidelines to assist health professionals. First Previous 27 28 29 30 31 Next Last
